Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02049918 · ClinicalTrials.gov registry record

Residual Sample Collection for Respiratory Viral Panel

A clinical trial of Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus, sponsored by GenMark Diagnostics.

Completed
Registry status
1,487
Enrollment target
1
Study location

NCT02049918: Completed study of Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus, sponsored by GenMark Diagnostics.

NCT02049918 is a study of Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus that has completed, run by GenMark Diagnostics. The registered enrollment target is 1,487 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02049918, a study of Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus, has completed, sponsored by GenMark Diagnostics.

COMPLETED
Registry status
1,487 participants
Enrollment target
1
Study location

Study Summary

Collect de-identified, residual samples to support a clinical trial. Samples may be prospectively or retrospectively collected. Overall Study Objective Obtain clinical performance data to characterize clinical performance of the Respiratory Viral Panel on the GenMark Sample-to-Answer Platform.

Primary Outcome

This is an IVD Diagnostic study.

Study Locations (1)

Pennsylvania

  • Penn State Hershey Medical Center - Hershey

Trial Details

FieldValue
Enrollment Target 1,487 participants
Start Date 2013-11
Est. Completion 2015-11
GenMark Diagnostics

1 total trials

What the finished NCT02049918 record still lists

NCT02049918 is an observational study that tracks outcomes without assigning an intervention. Its 1,487 participants enrollment target places it among the larger protocols in the corpus.

The record links to 1 condition, with Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus appearing as the primary indexed condition, and to 0 interventions.

NCT02049918 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT02049918 about?

NCT02049918 is a clinical study titled "Residual Sample Collection for Respiratory Viral Panel". Collect de-identified, residual samples to support a clinical trial. Samples may be prospectively or retrospectively collected. Overall Study Objective Obtain clinical performance data to characterize clinical performance of the Respiratory Viral Panel on the GenMark Sample-to-Answer Platform.

What is the current status of trial NCT02049918?

This trial is currently completed. The enrollment target is 1,487 participants. The study started on 2013-11. Estimated completion is 2015-11.

What conditions does trial NCT02049918 study?

This clinical trial studies the following conditions: Respiratory Viral Illnesses: Influenza A/B, RSV, Adenovirus.

Who is sponsoring clinical trial NCT02049918?

This trial is sponsored by GenMark Diagnostics, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02049918 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05869552 · 1,485 participants · NA

    Preventing Suicide Among Sexual and Gender Diverse Young Adults in Primary Care

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02049918, the US trial registry maintained by the National Library of Medicine. NCT02049918 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.